S. Seeber

519 total citations
14 papers, 426 citations indexed

About

S. Seeber is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, S. Seeber has authored 14 papers receiving a total of 426 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 4 papers in Pulmonary and Respiratory Medicine and 4 papers in Oncology. Recurrent topics in S. Seeber's work include Cancer Treatment and Pharmacology (3 papers), Synthesis of Tetrazole Derivatives (2 papers) and Testicular diseases and treatments (2 papers). S. Seeber is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Synthesis of Tetrazole Derivatives (2 papers) and Testicular diseases and treatments (2 papers). S. Seeber collaborates with scholars based in Germany and United States. S. Seeber's co-authors include A. Harstrick, Y M Rustum, H. Wilke, U. Vanhoefer, Ming Yin, Shu Cao, M. E. Scheulen, Dirk Strumberg, Ralf A. Hilger and J Moeller and has published in prestigious journals such as Journal of Clinical Oncology, European Journal of Cancer and International Journal of Clinical Pharmacology and Therapeutics.

In The Last Decade

S. Seeber

12 papers receiving 407 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
S. Seeber Germany	7	258	158	95	86	41	14	426
N Saijo Japan	12	277 1.1×	302 1.9×	53 0.6×	121 1.4×	54 1.3×	25	602
William G. Chapman United States	9	375 1.5×	319 2.0×	91 1.0×	64 0.7×	71 1.7×	9	630
Janet Ward United Kingdom	7	197 0.8×	144 0.9×	38 0.4×	44 0.5×	89 2.2×	8	419
KR Harrap United Kingdom	11	355 1.4×	252 1.6×	104 1.1×	36 0.4×	37 0.9×	21	602
W J van der Vijgh Netherlands	11	198 0.8×	141 0.9×	51 0.5×	65 0.8×	25 0.6×	11	439
Krakoff Ih United States	13	198 0.8×	156 1.0×	53 0.6×	47 0.5×	26 0.6×	24	440
Carol A. Cucchi United States	11	310 1.2×	445 2.8×	69 0.7×	53 0.6×	92 2.2×	15	734
Siham Djelloul France	7	311 1.2×	246 1.6×	44 0.5×	101 1.2×	63 1.5×	8	555
Joseph Zdanowicz United States	9	209 0.8×	180 1.1×	42 0.4×	34 0.4×	38 0.9×	10	399
L. R. HUGHES United Kingdom	10	163 0.6×	201 1.3×	80 0.8×	81 0.9×	21 0.5×	14	400

Countries citing papers authored by S. Seeber

Since Specialization

Citations

This map shows the geographic impact of S. Seeber's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Seeber with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Seeber more than expected).

Fields of papers citing papers by S. Seeber

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Seeber. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Seeber. The network helps show where S. Seeber may publish in the future.

Co-authorship network of co-authors of S. Seeber

This figure shows the co-authorship network connecting the top 25 collaborators of S. Seeber. A scholar is included among the top collaborators of S. Seeber based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Seeber. S. Seeber is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Emons, Günter, et al.. (2010). Antiproliferative effects of antiestrogens and inhibitors of growth factor receptor signaling on endometrial cancer cells.. PubMed. 30(6). 2025–31. 13 indexed citations

Seeber, S., et al.. (2008). Individualisierte Intervallverkürzung bei der chemotherapeutischen Induktionsbehandlung solider Tumoren. DMW - Deutsche Medizinische Wochenschrift. 106(51/52). 1741–1744.

Scheulen, M. E., et al.. (2004). Correlation of ERK-phosphorylation and toxicities in patients treated with the Raf kinase inhibitor BAY 43-9006. International Journal of Clinical Pharmacology and Therapeutics. 42(11). 648–649. 7 indexed citations

Díaz-Carballo, David, S. Seeber, Dirk Strumberg, & Ralf A. Hilger. (2003). Novel antitumoral compound isolated from Clusia rosea. International Journal of Clinical Pharmacology and Therapeutics. 41(12). 622–623. 30 indexed citations

Hilger, Ralf A., David Díaz-Carballo, Sebastian Bauer, et al.. (2003). Circadian rhythm in the regulation of the MAP kinase pathway pitfall in the determination of surrogate parameters?. International Journal of Clinical Pharmacology and Therapeutics. 41(12). 614–615. 1 indexed citations

Strumberg, Dirk, D. Voliotis, J Moeller, et al.. (2002). Results of phase I pharmacokinetic and pharmacodynamic studies of the Raf kinase inhibitor BAY 43-9006 in patients with solid tumors. International Journal of Clinical Pharmacology and Therapeutics. 40(12). 580–581. 92 indexed citations

Korfel, A., M. E. Scheulen, Hans‐Joachim Schmoll, et al.. (1998). Phase I clinical and pharmacokinetic study of titanocene dichloride in adults with advanced solid tumors.. PubMed. 4(11). 2701–8. 98 indexed citations

Rustum, Y M, A. Harstrick, Shu Cao, et al.. (1997). Thymidylate synthase inhibitors in cancer therapy: direct and indirect inhibitors.. Journal of Clinical Oncology. 15(1). 389–400. 162 indexed citations

Harstrick, A., N. Schleucher, Andrea J. Gonzales, et al.. (1995). 126 Interactions and cross resistance patterns between various schedules of 5-FU and the new, folate-based thymidilate synthase inhibitor tomudex (D1694). European Journal of Cancer. 31. S30–S30. 6 indexed citations

10.

Schmidt, C. G. & S. Seeber. (1979). Chemotherapie testikulärer Tumoren. DMW - Deutsche Medizinische Wochenschrift. 104(42). 1488–1493. 2 indexed citations

11.

Benker, G., et al.. (1977). Zytostatische Kombinationsbehandlung metastasierender Schilddrüsenkarzinome mit Doxorubicin und Bleomycin. DMW - Deutsche Medizinische Wochenschrift. 102(52). 1908–1913. 12 indexed citations

12.

Osieka, R., U. Bruntsch, W. M. Gallmeier, S. Seeber, & Christian Schmidt. (1976). Post-MOPP-Chemotherapie des Morbus Hodgkin. DMW - Deutsche Medizinische Wochenschrift. 101(32). 1177–1182. 2 indexed citations

13.

Osieka, R., et al.. (1974). Neue Zytostatika in der onkologischen Therapie. DMW - Deutsche Medizinische Wochenschrift. 99(48). 2468–2474. 1 indexed citations

14.

Warnecke, P. & S. Seeber. (1969). [Comparison of some antiphlogistics in the systems of neoplastic cells].. PubMed. 19(6). 975–7.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact